Table 1.

Patient demographics (intent-to-treat population)

	Nepafenac (n=76) n (%)	Ketorolac (n=73) n (%)	Placebo (n=76) n (%)
Age (mean years)	71.7	72.9	71.6
Sex
Male	34 (44.7)	28 (38.4)	28 (36.8)
Female	42 (55.3)	45 (61.6)	48 (63.2)
Race
Caucasian	74 (97.4)	70 (95.9)	73 (96.1)
Black	0	2 (2.7)	1 (1.3)
Asian	1 (1.3)	0	2 (2.6)
Hispanic	1 (1.3)	1 (1.4)	0

Note: No statistically significant differences were observed among groups.